Background: Women at high risk of developing breast cancer due to mutations in susceptibility
genes or a familial predisposition undergo adapted screening programs. However, the
timing of screening is still an issue, amongst others due to the occurrence of interval
cancers and because imaging is not possible during pregnancy and lactation. Therefore,
the multicenter, longitudinal, prospective TESTBREAST study aims to identify a novel
panel of blood-based protein biomarkers that enables early detection of breast cancer
for high-risk women using liquid biopsies, to improve the current screening program.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Surgical OncologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
ESSO40-0325
Identification
Copyright
© 2021 Published by Elsevier Inc.
